Timing of Levodopa Treatment in Parkinson's Disease

Completed · Phase 3

Conditions studied: Parkinson's Disease

In brief

The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).

Key facts

Study ID

NCT00004733

Run by

National Institute of Neurological Disorders and Stroke (NINDS)

Starts

1998-01-01

Expected to finish

2004-02-01

Last updated by the study team

2005-06-24

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Early, mild PD, not requiring medications
• Age 30 or older
• Duration from time of diagnosis of PD: less than 2 years
• Hoehn \& Yahr Stage 1 or 2
• Exposure to levodopa or dopamine agonist of 14 days or less

Where it is running

• Columbia University Health Sciences — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.